Severe Progressive Interstitial Lung Disease in Seronegative Immune-Mediated Necrotizing Myopathy: A Case Report
Immune-mediated necrotizing myopathy (IMNM) is a subtype of idiopathic inflammatory myopathy characterized by severe proximal weakness and myofiber necrosis with minimal inflammation. Interstitial lung disease (ILD) is uncommon in IMNM, particularly in seronegative cases, with limited published data on its clinical features. We present a 72-year-old man, a lifelong never-smoker, with previously diagnosed "idiopathic" ILD who presented with acute hypoxic respiratory failure. Despite negative myositis-specific antibodies and normal creatine kinase (CK), mildly elevated aldolase and magnetic resonance imaging (MRI) findings prompted muscle biopsy, which confirmed IMNM. He was treated with combination immunosuppression including corticosteroids, mycophenolate, rituximab, and intravenous immunoglobulin (IVIG), with significant improvement in respiratory and muscle function at six months and sustained respiratory and muscle function through 14–18 months of follow-up. This case demonstrates that seronegative IMNM can present with severe, progressive ILD. Normal CK should not exclude the diagnosis, particularly when muscle atrophy is present. Aldolase elevation and muscle biopsy are essential diagnostic tools in seronegative cases.
Authors
- Zachary Bondranko
- Ellen Yos
- Shannon Iriza (ORCID: https://orcid.org/0009-0007-7975-2123)
- HANNAH CASTLES
- Abhinav Gupta
Institutions
- Midlands Technical College (US)
Publication Details
- Journal
- Modern Rheumatology Case Reports
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1093/mrcr/rxag112
- Primary Topic
- Inflammatory Myopathies and Dermatomyositis
- Type
- article
- Field-Weighted Citation Impact
- 0.00